Joseph Thome

Stock Analyst at TD Cowen

(0)
# 4538
Out of 5,218 analysts
28
Total ratings
37.50%
Success rate
-13.86%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
Viridian Therapeutic...
Initiates Coverage On: Buy
n/a
n/a n/a 1 Nov 25, 2024
Marinus Pharma
Downgrades: Hold
n/a
n/a n/a 2 Oct 25, 2024
United Therapeutics
Maintains: Strong Buy
350 400
361.37 10.69% 2 Oct 21, 2024
Rapport Therapeutics
Initiates Coverage On: Buy
n/a
n/a n/a 1 Jul 2, 2024
Aerovate Therapeutic...
Downgrades: Hold
n/a
n/a n/a 2 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
30.46 11.62% 1 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
80 90
83.02 8.41% 2 Apr 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
32 30
46.45 -35.41% 2 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
45
n/a n/a 2 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Oct 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
120 130
90.01 44.43% 2 Jun 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
2
n/a n/a 1 Jun 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jan 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 15, 2021